Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | CASP3 | P42574 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | TNF | P01375 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12531899 | 0.91 | ATM (0.53) | MDM4TP53CASP3TNF | |
| SCHEMBL29401932 | 0.91 | ATM (0.53) | MDM4TP53CASP3TNF | |
| SCHEMBL13743302 | 0.91 | ATM (0.53) | MDM4TP53CASP3TNF | |
| SCHEMBL2977877 | 0.91 | ATM (0.53) | MDM4TP53CASP3TNF | |
| SCHEMBL29440768 | 0.91 | MDM4 (0.59) | MDM4TP53CASP3KMT2ATNF | |
| SCHEMBL119455 | 0.91 | MDM4 (0.59) | MDM4TP53CASP3KMT2ATNF | |
| SCHEMBL29367434 | 0.91 | MDM4 (0.59) | MDM4TP53CASP3KMT2ATNF | |
| SCHEMBL1228254 | 0.91 | MDM4 (0.59) | MDM4TP53CASP3KMT2ATNF | |
| SCHEMBL118169 | 0.91 | MDM4 (0.59) | MDM4TP53CASP3KMT2ATNF | |
| SCHEMBL29398498 | 0.91 | MDM4 (0.59) | MDM4TP53CASP3KMT2ATNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014153624-A1 | ANTIBACTERIAL COMPOUNDS | THE UNIVERSITY OF SYDNEY (AU) | 2014-10-02 | — | — | WO | disclosed |
| EP-0474506-B1 | Antimicrobial peptides | MORINAGA MILK INDUSTRY CO LTD (JP) | 1998-05-13 | — | — | EP | disclosed |
| EP-0629213-B1 | USE OF AN IMMUNOSTIMULATORY AGENT | MORINAGA MILK INDUSTRY CO LTD (JP) | 1996-10-23 | — | — | EP | disclosed |
| US-5466669-A | Polypeptides | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 1995-11-14 | — | — | US | disclosed |
| EP-0629213-A1 | IMMUNOSTIMULATORY AGENT. | MORINACA MILK INDUSTRY CO LTD (JP) | 1994-12-21 | — | — | EP | disclosed |
| US-5304633-A | Polypeptides | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 1994-04-19 | — | — | US | disclosed |
| WO-1993018061-A1 | IMMUNOSTIMULATORY AGENT | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 1993-09-16 | — | — | WO | disclosed |
| EP-0474506-A1 | Antimicrobial peptides | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 1992-03-11 | — | — | EP | disclosed |
| US-4753985-A | Synthesis of organic compounds using deformable gel in porous rigid support | UNITED KINGDOM ATOMIC ENERGY AUTHORITY (GB) | 1988-06-28 | — | — | US | disclosed |